ACADIA Pharmaceuticals reported a GAAP loss of $124.776 million for 9M 2021, down 41.9% from $214.824 million in the previous year. Revenue increased 10.2% to $353.387 million from $320.748 million a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept